{"id":57011,"date":"2026-02-12T22:29:10","date_gmt":"2026-02-12T14:29:10","guid":{"rendered":"https:\/\/flcube.com\/?p=57011"},"modified":"2026-02-12T22:29:11","modified_gmt":"2026-02-12T14:29:11","slug":"therom-fishers-ppd-partners-with-datavant-to-integrate-real-world-data-into-clinical-trials","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=57011","title":{"rendered":"Therom Fisher\u2019s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials"},"content":{"rendered":"\n

Thermo Fisher Scientific Inc.<\/strong> (NYSE:\u202fTMO<\/a><\/strong>) announced a strategic partnership<\/strong> between its PPD clinical research business<\/strong> and Datavant Inc.<\/strong>, the US-based health data connectivity platform<\/strong>, to integrate and analyze real-world data (RWD)<\/strong> across clinical trial operations<\/strong>. The collaboration will enhance randomized trials<\/strong> with RWD enrichment<\/strong>, leverage PPD CorEvitas Clinical Registries<\/strong>, and optimize PPD Evidera solutions<\/strong> through Datavant’s privacy-preserving tokenization technology<\/strong>.<\/p>\n\n\n\n

Partnership Structure<\/h2>\n\n\n\n
Element<\/th>Detail<\/th><\/tr><\/thead>
Technology Provider<\/strong><\/td>Thermo Fisher Scientific Inc. (NYSE:\u202fTMO) \u2013 PPD clinical research business<\/td><\/tr>
Data Connectivity Partner<\/strong><\/td>Datavant Inc. (US-based health data platform)<\/td><\/tr>
Collaboration Focus<\/strong><\/td>Real-world data (RWD) integration and analysis<\/td><\/tr>
Applications<\/strong><\/td>RWD-enriched randomized trials; CorEvitas registries; Evidera solutions<\/td><\/tr>
Datavant Network<\/strong><\/td>350+ RWD partners; 80,000+ US hospitals and clinics<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Technology Integration & Capabilities<\/h2>\n\n\n\n
Datavant Capability<\/th>PPD Application<\/th>Strategic Value<\/th><\/tr><\/thead>
Tokenization & Linking<\/strong><\/td>Patient-level data connectivity<\/strong> across disparate sources<\/td>De-identified dataset integration<\/strong> without privacy compromise<\/td><\/tr>
Privacy Preservation<\/strong><\/td>Secure EMR retrieval<\/strong> for customized RWD generation<\/td>Regulatory compliance<\/strong> (HIPAA, GDPR); patient trust maintenance<\/strong><\/td><\/tr>
Network Scale<\/strong><\/td>80,000+ US healthcare facilities<\/strong><\/td>Comprehensive real-world evidence<\/strong> capture; generalizability enhancement<\/strong><\/td><\/tr>
RWD Enrichment<\/strong><\/td>Randomized clinical trial augmentation<\/strong><\/td>External control arms<\/strong>; long-term safety monitoring<\/strong>; efficacy validation<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Strategic Rationale & Market Context<\/h2>\n\n\n\n
Factor<\/th>Industry Analysis<\/th><\/tr><\/thead>
Real-World Evidence (RWE) Demand<\/strong><\/td>FDA, EMA, NMPA<\/strong> increasingly accepting RWE for regulatory decisions<\/strong>; post-market requirements<\/strong> expanding; RWD integration<\/strong> critical for accelerated approvals<\/strong><\/td><\/tr>
Clinical Trial Efficiency<\/strong><\/td>RWD enrichment<\/strong> reduces trial costs<\/strong> and timelines<\/strong>; external comparators<\/strong> enable smaller control arms<\/strong>; post-trial follow-up<\/strong> without patient burden<\/td><\/tr>
PPD Competitive Positioning<\/strong><\/td>Thermo Fisher’s CRO scale<\/strong> + Datavant connectivity<\/strong> creates differentiated RWD-enabled trial offering<\/strong> vs. IQVIA, Syneos, Parexel<\/strong><\/td><\/tr>
CorEvitas & Evidera Synergy<\/strong><\/td>Autoimmune and rare disease registries<\/strong> (CorEvitas) + health economics expertise<\/strong> (Evidera) enhanced by Datavant’s longitudinal data linking<\/strong><\/td><\/tr>
Privacy-First Design<\/strong><\/td>Tokenization technology<\/strong> addresses data governance concerns<\/strong>; enables cross-border RWD utilization<\/strong> for global trials<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Implementation & Commercial Outlook<\/h2>\n\n\n\n
Priority<\/th>Execution Plan<\/th>Timeline<\/th><\/tr><\/thead>
Technology Integration<\/strong><\/td>Datavant APIs embedded in PPD trial management systems<\/td>2026<\/td><\/tr>
Pilot Programs<\/strong><\/td>RWD-enriched trials in oncology, immunology, rare disease<\/td>2026-2027<\/td><\/tr>
Regulatory Engagement<\/strong><\/td>FDA\/EMA RWE framework alignment; qualification pathways<\/td>Ongoing<\/td><\/tr>
Global Expansion<\/strong><\/td>International RWD partner network expansion (EU, Asia-Pacific)<\/td>2027-2028<\/td><\/tr>
Commercialization<\/strong><\/td>Premium RWD-enabled trial offerings; outcome-based contracts<\/td>2027+<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Forward\u2011Looking Statements<\/strong>
This brief contains forward\u2011looking statements regarding Thermo Fisher PPD and Datavant partnership execution, RWD integration in clinical trials, and real-world evidence regulatory acceptance. Actual results may differ due to data privacy regulation changes, healthcare system interoperability challenges, and competitive responses from IQVIA and other CROs.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Thermo Fisher Scientific Inc. (NYSE:\u202fTMO) announced a strategic partnership between its PPD clinical research business…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1261,523],"class_list":["post-57011","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-nyse-tmo","tag-thermo-fisher-scientific"],"yoast_head":"\nTherom Fisher\u2019s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Thermo Fisher Scientific Inc. (NYSE:\u202fTMO) announced a strategic partnership between its PPD clinical research business and Datavant Inc., the US-based health data connectivity platform, to integrate and analyze real-world data (RWD) across clinical trial operations. The collaboration will enhance randomized trials with RWD enrichment, leverage PPD CorEvitas Clinical Registries, and optimize PPD Evidera solutions through Datavant's privacy-preserving tokenization technology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=57011\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Therom Fisher\u2019s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials\" \/>\n<meta property=\"og:description\" content=\"Thermo Fisher Scientific Inc. (NYSE:\u202fTMO) announced a strategic partnership between its PPD clinical research business and Datavant Inc., the US-based health data connectivity platform, to integrate and analyze real-world data (RWD) across clinical trial operations. The collaboration will enhance randomized trials with RWD enrichment, leverage PPD CorEvitas Clinical Registries, and optimize PPD Evidera solutions through Datavant's privacy-preserving tokenization technology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=57011\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-12T14:29:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-12T14:29:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57011#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57011\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Therom Fisher\u2019s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials\",\"datePublished\":\"2026-02-12T14:29:10+00:00\",\"dateModified\":\"2026-02-12T14:29:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57011\"},\"wordCount\":404,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NYSE: TMO\",\"Thermo Fisher Scientific\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=57011#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57011\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=57011\",\"name\":\"Therom Fisher\u2019s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-02-12T14:29:10+00:00\",\"dateModified\":\"2026-02-12T14:29:11+00:00\",\"description\":\"Thermo Fisher Scientific Inc. (NYSE:\u202fTMO) announced a strategic partnership between its PPD clinical research business and Datavant Inc., the US-based health data connectivity platform, to integrate and analyze real-world data (RWD) across clinical trial operations. The collaboration will enhance randomized trials with RWD enrichment, leverage PPD CorEvitas Clinical Registries, and optimize PPD Evidera solutions through Datavant's privacy-preserving tokenization technology.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57011#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=57011\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57011#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Therom Fisher\u2019s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Therom Fisher\u2019s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials - Insight, China's Pharmaceutical Industry","description":"Thermo Fisher Scientific Inc. (NYSE:\u202fTMO) announced a strategic partnership between its PPD clinical research business and Datavant Inc., the US-based health data connectivity platform, to integrate and analyze real-world data (RWD) across clinical trial operations. The collaboration will enhance randomized trials with RWD enrichment, leverage PPD CorEvitas Clinical Registries, and optimize PPD Evidera solutions through Datavant's privacy-preserving tokenization technology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=57011","og_locale":"en_US","og_type":"article","og_title":"Therom Fisher\u2019s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials","og_description":"Thermo Fisher Scientific Inc. (NYSE:\u202fTMO) announced a strategic partnership between its PPD clinical research business and Datavant Inc., the US-based health data connectivity platform, to integrate and analyze real-world data (RWD) across clinical trial operations. The collaboration will enhance randomized trials with RWD enrichment, leverage PPD CorEvitas Clinical Registries, and optimize PPD Evidera solutions through Datavant's privacy-preserving tokenization technology.","og_url":"https:\/\/flcube.com\/?p=57011","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-02-12T14:29:10+00:00","article_modified_time":"2026-02-12T14:29:11+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=57011#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=57011"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Therom Fisher\u2019s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials","datePublished":"2026-02-12T14:29:10+00:00","dateModified":"2026-02-12T14:29:11+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=57011"},"wordCount":404,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NYSE: TMO","Thermo Fisher Scientific"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=57011#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=57011","url":"https:\/\/flcube.com\/?p=57011","name":"Therom Fisher\u2019s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-02-12T14:29:10+00:00","dateModified":"2026-02-12T14:29:11+00:00","description":"Thermo Fisher Scientific Inc. (NYSE:\u202fTMO) announced a strategic partnership between its PPD clinical research business and Datavant Inc., the US-based health data connectivity platform, to integrate and analyze real-world data (RWD) across clinical trial operations. The collaboration will enhance randomized trials with RWD enrichment, leverage PPD CorEvitas Clinical Registries, and optimize PPD Evidera solutions through Datavant's privacy-preserving tokenization technology.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=57011#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=57011"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=57011#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Therom Fisher\u2019s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57011","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=57011"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57011\/revisions"}],"predecessor-version":[{"id":57013,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57011\/revisions\/57013"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=57011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=57011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=57011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}